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A B S T R A C T 
The data from a 10-years prospective study among 85 boys and 64 girls, mean age 14,1 ±3,8 years with mean 
diabetes duration 8,45 ±3,7 years are analyzed. Using a complex prospective screening we found the frequency 
of microalbuminuria (MAU) and estimated some parameters of progression of the renal damage. The patients 
were divided into 3 groups: no MAU, with M A U and with clinical signs of nephropathy. We traced the dynam-
ics of glomerular fdtration, albumin excretion and arterial pressure. The effect of A C E I s was according to the 
level of proteinuria. In diabetics with macroalbuminuria a short-lasting effect run out to the end of the 2-nd 
year. In MAU-positive ptients A C E I s led to delay of nephropathy for 10-years in 86,48%, progression in 8,1% 
and regression to normoalbuminuria in 5,4%. In 15% of all the diabetics we found a significant raise of 
proteinuria. In 21,73% of patients with "borderline" albuminuria there was a progression after the 5-th year 
with a cumulative index 4,58% or 0,91%. 
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I N T R O D U C T I O N 
Diabetes mellitus ( D M ) as a group of metabolic diseases, 
characterizing with hyperglycemia is a result of offence in 
insulin secretion, insulin action or (and) both (9,10) and 
damages all organs and systems in the organism, but con-
cerns most o f all the blood vessels (1). Nowadays a 112 000 
healthy Bulgarian child is diabetic and the annual incidence 
rate of disease is 7-10/100 000 children (4) . The renal in-
volvement in D M is the second very important complica-
tion and its clinical appearance is 5.45% (6). 
M A T E R I A L AND M E T H O D S 
Using a complex prospective screening to establish the fre-
quency o f microalbuminuria ( M A U ) as a marker of an ini-
tial diabetic nephropathy ( D N P ) in children and adoles-
cents, to trace its evolution, by assessing the indexes of pro-
gression: M A U , blood pressure ( B P ) and glomerular filtra-
tion rate ( G F R ) for a 10-year period. 
We studied 149 patients with D M type-1, 85 boys and 64 
girls, mean age 14.1 ±3.8 years and D M duration 8.45 ±3.7 
years for a 10-years period. In 89 patients (59.73%) the 
treatment was conventional insulin regimen and in 60 pa-
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tients (40.27%) - intensified insulin regimen with human 
insulin ( H M ) . The patients fonned 2 groups, according to 
the albumin excretion ( A E ) : diabetics without M A U (109), 
diabetics with M A U (37) and 3 patients withdrew the 
study, because o f their macroalbuminuric excretion. 
1. M A U : 
1) semi-quantitative methods: a 24h urine sample with 
immunochemical tests: a) Micral (Boehringer -
Mannheim); b) Microbumintest (Miles Inc., U S A ) 
2) a quantitative method: immunoturbidometry with 
analyzer Cobas mira plus (Hoffman-La Roche) 
with Randox test, using original program: Randox 
urinary albumin control-low and elevated; 
sensitivity limits: 9.7-206.2 mg/1 albumin in urine. 
2. G F R : a) standard 4h - creatinine clearance - normal 
values: 60-100ml/min/1.73mI; b) Tc-99m D T P A 
clearance - normal values 180-236ml/min/1.73ml, 
"Diacanf', Siemens 
3. Metabolic control: IMX-Abbot, U S A by M E I A 
method; referent values of HbAlc-4.4-6.4%. 
4. Test for provoking M A U by graded exercise - using 
veloergometry type K E 22 Medicor, Budapest on 75W 
and 100W by original method for children and 
adolescents. 
5. Sphygmomanometry: with aneroid sphygmo-
manometer, using Korotkoff method (Vth phase): in 
rest and at graded exercise 
6. Dynamic renal scintigraphy with Tc-99m D T P A using 
"Diacam*' (Siemens) for the first time in Bulgaria 
(Varna) for studying an initial DNP. 
7. Indexes for progression: a) A E : 
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1) raising o f A E versus the initial values per year 
(ug/min/year or mg/l/year); 
2) % o f its raising versus the initial per year (A%/year): 
b) G F R : 1/ rate of reduction o f G F R (ml/min/month or 
ml/min/year); 21% of its reduction versus the initial (supra-
nonnal) per year (Д%/уеаг) 
3) B P : 
1) raising o f B P versus the initial per year (mm 
Hg/year); 
2) % of raising B P versus the initial per year -
(Д%/уеаг). 
We used the following statistic methods: graphic analysis, 
alternative analysis, statistic assessment, variation analysis 
- statistic significant is the value under 5% (p < 0.05) and 
Microsoft Excel - Windows' 98 for data processing. 
R E S U L T S AND D I S C U S S I O N 
In our study for a 10-years period 5 of nonnoalbuminuric 
patients progressed to M A U after the 5-th year and all were 
in the beginning with borderline albuminuria, litis showed 
a cumulative risk o f 4.58% (5/109 patients). 
In the M A U-group, treated with angiotensin-converting en­
zyme inhibitors ( A C E I ) , 3 patients developed 
macroalbuminuria or the progression in MAU-diabetics 
was 8.10% for the treated patients . In the normoalbuinuric 
patients there were 23 with borderline values: 
7.2-20ug/min. After the 5-th year 5 of them progressed to 
microalbuminuria, so 8 diabetics fell in the group of 
progressors. Their share was 5.48% of all examined cases. 
In the MAU-diabetics, 2 patients regressed to normal albu­
min excretion, using Enalapril (Renitec). The values of their 
M A U were not so high - between 50-70mg/ml or the share 
of diabetics "regressors" was 5.40% among the 
MAU-group. 
I f we show the data for the evolution of proteinuria, B P and 
G F R for the 10 years in the different groups of patients ac­
cording to A E , G F R and B P , we wil l receive the following 
results: (Tables 1,2 and 3; Figures 1, 2, 3 and 4). 
2 years 5 years 10 years 
Fig. 1. Dynamics of proteinuria for 10 years 
Our results about the dynamics of proteinuria in children 
and adolescent diabetics correlate with these reported by 
ather authors. According to the data of patients in the 
Microalbuminuria Captopril Study Group (1996), in 7.2% 
?f the cases there was a progression of the persistent M A U 
during 24 months (6). Ahmad et al. showed that for 5-years 
treatment with Enalapril - 7 . 7 % of their patients developed 
macroalbuminuria (3). 
2 years 5 years 10 years 
Fig. 2. Dynamics of GFR for 10 years 
The data for 5.40% regression in our MAU-patients are 
corresponding to El l is et al. (5) . For a 4-year period 7 out of 
124 patients (5.64%) with D N P undergone a reverse devel­
opment to normal albuminuria and in 33.87% there was an 
improvement (5). 
normo-AU borderline micro-AU 
Fig. 3. Dynamics of systolic BP for 10 years 
We consider that the most vulnerable and suitable for active 
observation is the group of adolescent diabetics with bor­
derline albuminuria. Their evolution shows that almost 1/5 
of them (21.74%) are progressors towards M A U and even­
tually to clinical D N P . These are patients in puberty, worse 
metabolic control and more often (40%) with familial pre­
disposition to hypertension (2 out of 5 progressors in the 
group of borderline albuminuria). So they possess determi­
nant risk factors like the patients with initial D N P (the 
MAU-group). 
njnno-AU borderline micro-AU 
Fig. 4. Dynamics of diastolic BP for 10 years 
When MAU-patients are early treated with A C E I they have 
a stable course of A E and in 91.89% the renal function did 
not get worse. We establish that there is not a significant 
difference in the reduction of G F R using various A C E I . 
Values of 2.3 ml/min/year are average referent values, 
mentioned in the literature (4,8,11). 
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ible I . Dynamics of proteinuria for 10 years 
Groups of pts: In the beginning; After 2 years: After 5 years: At the 10d'vear: 
Nonno - A U 2,1 ±0 ,2 2,18 ±0,3 2,29 ±0,32 2,48 ± 0,42 
Borderline - A U 2,42 ±0 ,3 2,46 ±0,38 2,49 ±0,43 2,51 ±0,56 
Micro - A U 6,93 ± 0,32 9,8 ± 0,40 23,6 ±0,36 25,2 ±0,2 
able 2. dynamics ofDFRfor 10years 
Groups of pts: In the beginning: After 2 years: After 5 years: At the 1 О* year: 
Normo- A U 108,6 ±4,5 109,4 ±3 ,9 110,0 ±4,1 115,2 ±4,4 
Borderline - AU 1 I0.3r. 3.4 117,4 ±3 ,9 119,3 ±4 ,6 121,5 ±3 ,7 
hyphparOMicro - A U 135,4 ±4,1 139,4 ±4 ,3 128,3 ±3 ,9 125,4 ±3 ,8 
Table 3. Dynamics of BP for 10 years 
Groups of pts: BP (mmHg) In the beginning: After 2 years: After 5 years: At the 10th year: 
Nonno- A U 
SBP 103,6 ± 11,3 104,4 ± 13,9 106,3 ± 14,1 108,2± 14,4 NS 
DBP 67,6 ± 15,7 68,1 ± 11,4 69,0 ± 12.6 70.9 ±10,8 NS 
Borderline-AU 
SBP 113,6 ± 14,8 114,9 ± 13,9 117,3 ± 14,1 118,8 ± 13,7 p<0.06 
DBP 72,4 ± 16,7 73,2 ± 14,8 76,3 ± 12,9 78,9 ±13,4 p<0.05 
Micro - A U 
SBP 114,6 ±21,2 115,4 ± 18,3 117,6 ± 13,9 118,4± 13,4 p<0.06 
DBP 72.6 - 17,4 74,5 ± 17,3 77,4 ± 15,8 81,3 ±14,3 p- 0.01 
fact that in 8.1 % of MAU-positive patients there is a 
progression and in 5.4% regression of the renal complica­
tion shows that D N P has not an inevitable malignant 
course, which justifies early therapeutic interference even in 
childhood. 
C O N C L U S I O N S 
1. The frequency of M A U in our patients is 24.83% 
2. Some 2 1 . 1 % of normoalbuminuric patients are with 
borderline albuminuria; in 5 o f them (21.74%) it 
progresses for 5 years to M A U with cumulative index 
0.91 % per year. 
3. In MAU-positive group the treatment with A C E I 
avoids the progression for 10 years in 86.48%, 
progression in 8.2% and regression to normal albumin 
excretion in 5.40%. 
4. Diastolic B P doesn't change significantly by graded 
exercise, but raises significantly in MAU-positive 
patients and correlates with the elevated albumin 
excretion for the 10-year period. 
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